• LIRP Enables Light-Controlled Gene Therapy Translation

  2026-09-29

  The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at translation initiation, keeping expression low in darkness and permitting it under blue or ambient light. In mouse models, LIRP-regulated AAV systems supported light-responsive treatment concepts for diet-induced obesity and retinal neovascular disease, while also highlighting the practical challenges of tissue illumination, durability, and clinical translation.

• Camostat Mesilate: From Protease Biology to Translation

  2026-09-29

  Camostat Mesilate offers a mechanistically focused way to study ENaC-linked protease signaling, plasmin–TGF-β biology, and hepatic fibrosis. This thought-leadership analysis places the compound alongside structure-guided antiviral proteomimetics, clarifying where the mechanisms converge, where they remain distinct, and how translational researchers can design more informative experiments.

• Novobiocin Against Equine Piroplasms: Hsp90 Study

  2026-09-28

  The reference study evaluates Novobiocin as an Hsp90-directed antiparasitic agent against cultured Theileria equi and Babesia caballi, combining parasite growth assays with equine host-cell safety testing and mouse organ-toxicity assessment. Its findings support parasite Hsp90 as a promising target while emphasizing that in vitro selectivity and preliminary tolerability require validation in infected horses.

• Carbenoxolone disodium: Protocol and QC Guide

  2026-09-28

  Carbenoxolone disodium is a research perturbation tool for studying 11β-hydroxysteroid dehydrogenase activity, glucocorticoid regulation, and gap junction communication in cell- and tissue-based workflows. Use it with vehicle, viability, and orthogonal pathway controls; the supplied product information does not establish it as a selective probe or support claims of in vivo efficacy.

• Amyloid Beta-Peptide (1-40): Microglial Signaling

  2026-09-27

  Amyloid Beta-Peptide (1-40) (human) is often studied for aggregation and neuronal effects, but peptide state can also shape how researchers interpret microglial responses. This article examines a reported APP–G-protein pathway and translates its implications into careful, state-aware assay decisions.

• Biotin (Vitamin B7) in Motor and Metabolic Assays

  2026-09-26

  Use Biotin (Vitamin B7) to support carboxylase-focused metabolism studies and to control avidin–streptavidin steps in carefully designed assays. For kinesin experiments, distinguish free biotin from activated biotinylation reagents: the former can serve as a soluble competitor or control, while the latter is needed for covalent protein labeling.

• FPH1 (BRD-6125): Hepatocyte Assay Guide

  2026-09-25

  A practical guide to using FPH1 (BRD-6125) in hepatocyte proliferation and function workflows, with formulation, dosing, and interpretation considerations. Includes product-specific handling details for SKU B3701 and guidance for choosing fit-for-purpose readouts.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody

  2026-09-25

  This affinity-purified, HRP-labeled secondary antibody detects rabbit IgG primary antibodies in workflows such as Western blotting, ELISA, and immunohistochemistry. It supports research detection only; it is not intended for diagnostic or medical use, and assay-specific working dilutions should be established during validation.

• Zolmitriptan and Causal Assay Design

  2026-09-24

  Zolmitriptan is a 5-HT1B receptor agonist that helps researchers interrogate migraine-related signaling. This article focuses on a less-explored question: how to separate receptor engagement from downstream outcomes, using a lysosomal antiviral study to illustrate rigorous assay interpretation—not to imply a shared mechanism.

• GSK 2837808A for Reliable LDHA Assays

  2026-09-24

  Learn how GSK 2837808A (SKU B4929) can support carefully controlled LDHA and cancer-metabolism experiments, from viability-assay design to interpretation of lactate readouts. The guide distinguishes reported biochemical potency and hepatocellular carcinoma findings from questions that still require validation in other cell models.

• FPH1 (BRD-6125): Functional Hepatocyte Expansion

  2026-09-23

  FPH1 (BRD-6125) offers a way to study hepatocyte expansion alongside measures of differentiated function. This article explains how to interpret growth and functional readouts together—and how a separate light-controlled gene-regulation study informs assay design without implying a direct connection to FPH1.

• Pulchinenoside B4 Targets CD1d–NLRP3 Colitis

  2026-09-23

  A 2025 study shows that Pulchinenoside B4 protects against DSS-induced colitis by acting through a macrophage CD1d–NLRP3 inflammasome axis rather than by broadly suppressing intestinal inflammation. Its combination of knockout models, cell-specific analyses, biolayer interferometry, and CETSA connects CD1d to the AKT–STAT1–PRDX1–NF-κB pathway and provides a mechanistic framework for inflammation research.

• Beclin1, Ferroptosis, and Doxorubicin Liver Injury

  2026-09-22

  The reference study identifies Beclin1 as a contributor to doxorubicin-induced liver injury by linking excessive autophagy with ferroptotic lipid damage. Its loss-of-function and DHODH overexpression experiments suggest that the Beclin1–DHODH relationship may be an important regulatory axis connecting oxidative stress, iron handling, and hepatocyte injury.

• CHI3L1-IN-5 (Compound Z17) Assay Guide

  2026-09-22

  A scenario-based guide to using CHI3L1-IN-5 (Compound Z17, CAS No. 2249043-42-1; SKU C8756) in astrocyte viability, NF-κB, amyloid-β uptake, and lysosomal assays. It covers dose design, vehicle controls, interpretation, storage, and practical vendor-selection criteria for more defensible neuroinflammation experiments.

• (R,S)-Anatabine Workflow for Alzheimer’s Research

  2026-09-21

  Build a stronger Alzheimer’s disease workflow around (R,S)-Anatabine by pairing soluble Aβ measurements with APP processing, BACE-1, and NF-κB readouts. This practical guide separates evidence-backed findings from pilot parameters and shows how to troubleshoot solvent, timing, and assay-specific failures.

7894 records 1/527 page Next 12345 下5页 Last page